ProfileGDS4459 / ENSG00000100033
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 23% 31% 14% 18% 13% 13% 17% 17% 14% 9% 8% 16% 15% 19% 20% 26% 25% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.4723
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.831
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.5814
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.4118
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.6713
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.8213
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.8517
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.7917
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.614
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.329
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.488
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.6616
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.7515
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.3919
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.9420
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.626
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.5825